Company Profile
Proteogenix is a leading life science company providing solutions and services in molecular biology and immunology. Our customers have been witnessing our proven expertise in the fields of antibodies, proteins, peptides and genes since 2003. Our commitment is to give them access to comprehensive and integrative solutions to develop the tools they need to efficiently conduct their research work.
Starting from the synthesis of your gene we develop all the material required for any immunoassay and we can undertake studies such as large epidemiology analysis on tissue microarrays. Our exceptional functional and technical expertise coupled with extensive scientific knowledge makes Proteogenix the most reliable partner to develop antibodies, produce proteins and synthesize genes (cDNA) and peptides.
We also provide the research community with a wide range of commercial products available on our website such as antibodies, proteins, ELISA kits, tissue microarrays, chimera RNAi, molecular biology products, 2100 retriever (IHC unmasking tool), etc.
Besides, we research and develop innovative diagnostic and screening products for cancers. Indeed, thanks to our one hybrid screening platform, we identify new interesting targets that we validate through corresponding antibodies and proteins designed especially for it. ELISA assays are designed to characterize target expression on human patient serum samples. 5 targets are currently being developed at different stages of progression. The company’s mission is to offer to the health community new tools for the diagnostic and screening of cancers in order to actively participate in decreasing morbidity related to these ever more frequent pathologies. The marketing of our know-how in molecular and cellular biology and immunology contributes to the financing of R&D work required to meet this goal.
Proteogenix will move in brand new state of the art facilities by 2011 :





